Bioage labs inc
WebMay 16, 2024 · About BioAge Labs, Inc. BioAge is a clinical-stage biotechnology company developing a pipeline of treatments to extend healthy lifespan by targeting the molecular causes of aging. The company uses its discovery platform, which combines quantitative analysis of proprietary longitudinal human samples with detailed health records tracking ... WebApr 14, 2024 · BioAge Labs Inc. of Richmond looks to take the drug — called BGE-105 — into a clinical trial in humans early next year. It will target muscle aging, one of the most obvious results of ...
Bioage labs inc
Did you know?
WebOct 13, 2024 · About BioAge Labs, Inc. BioAge is a clinical-stage biotechnology company developing a pipeline of treatments to extend healthy lifespan by targeting the molecular causes of aging. The company uses its discovery platform, which combines quantitative analysis of proprietary longitudinal human samples with detailed health records to map … WebFounded Date 2015. Founders Eric Morgen, Kristen Fortney. Operating Status Active. Last Funding Type Series C. Legal Name BioAge Labs, Inc. Company Type For Profit. Contact Email [email protected]. BIOAGE …
WebRedefining healthy aging with longevity- focused therapeutics. We are building a broad portfolio of drugs to address acute diseases of aging. Our medicines will expand the … Company Our mission Develop a pipeline of treatments that extend healthy lifespan … WebDec 3, 2024 · RICHMOND, Calif., Dec. 03, 2024 (GLOBE NEWSWIRE) -- BioAge Labs, Inc., a biotechnology company developing medicines to treat aging and aging-related …
WebFind company research, competitor information, contact details & financial data for Bioage Labs, Inc. of Richmond, CA. Get the latest business insights from Dun & Bradstreet. …
WebDec 3, 2024 · BIOAGE LABS has raised a total of $123.9M in funding over 3 rounds. Their latest funding was raised on Dec 3, 2024 from a Series C round. BIOAGE LABS is funded by 11 investors. Elad Gil and Felicis are the most recent investors. BIOAGE LABS has a post-money valuation in the range of $100M to $500M as of Dec 6, 2024, according to …
WebDec 5, 2024 · RICHMOND, Calif., December 05, 2024 -- ( BUSINESS WIRE )--BioAge Labs, Inc. ("BioAge"), a clinical-stage biotechnology company developing therapeutics … grant employee time trackingWebApr 19, 2024 · RICHMOND, Calif.--(BUSINESS WIRE)--BioAge Labs, Inc., a biotechnology company developing therapeutics that target the molecular causes of aging to extend healthy human lifespan, today announced ... chip and nails cabinetsWebBioAge Labs 7,187 followers on LinkedIn. We are mapping human aging to develop a pipeline of therapies to treat disease and extend healthy lifespan. BioAge is a platform-driven, clinical-stage biotechnology company that is mapping human aging to develop a pipeline of therapies that treat disease and extend healthy lifespan. Our proprietary … chip and modWebMar 22, 2024 · RICHMOND, Calif.--(BUSINESS WIRE)--BioAge Labs, Inc., a clinical-stage biotechnology company developing medications that target aging to treat severe diseases, today announced that it has ... chip and nikki headleyWebApr 6, 2024 · CHENGDU, China-- ( BUSINESS WIRE )--Shanghai Stock Exchange listed biotech company HitGen Inc. (“HitGen”) announced important research progress in a … chip and non chip formingWebMay 16, 2024 · About BioAge Labs, Inc. BioAge is a clinical-stage biotechnology company developing a pipeline of treatments to extend healthy lifespan by targeting the molecular causes of aging. granter healthcareWebAug 19, 2024 · August 19, 2024 08:00 AM Eastern Daylight Time. RICHMOND, Calif.-- ( BUSINESS WIRE )--BioAge Labs, Inc., a clinical-stage biotechnology company developing medications that target the molecular ... grant erickson chiropractor